Massive 28,000-Person study tests which diabetes drug better prevents heart failure hospitalizations

This study analyzed real-world medical records to compare two diabetes medications, tirzepatide and semaglutide, in people who also have a specific type of heart failure. Researchers looked at over 28,000 adults with type 2 diabetes and heart failure to see which drug was better at preventing death or hospitalization for heart problems. The goal was to understand if real-world data can reliably answer questions about which existing treatments work best for complex conditions.